In terms of data analysis, it may have been beneficial to include other blood biomarkers of insulin resistance, such as fasting insulin, C-peptide, and fructosamine, to further assess and confirm the impact of the intervention [79,80]. This evidence concerns the gene INS and Insulin resistance.